| 1 |
Misra DP, Singh K, Rathore U, Patro P, Tomelleri A, Campochiaro C, Agarwal V, Sharma A. The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysis. Autoimmun Rev 2023;22:103275. [PMID: 36652977 DOI: 10.1016/j.autrev.2023.103275] [Reference Citation Analysis]
|
| 2 |
Gao S, Wu ZY, Miao YQ, Lu ZB, Tan SP, Wang JY, Lu CR, Xu ZX, Li P, Lan Y, Diao YP, Chen ZG, Li YJ. Design and Protocol for Beijing Hospital Takayasu Arteritis (BeTA) Biobank. J Clin Med 2023;12. [PMID: 36836051 DOI: 10.3390/jcm12041516] [Reference Citation Analysis]
|
| 3 |
Misra DP, Agarwal V. Biomarkers of Takayasu arteritis - Circulating cells, metabolomics, composite scores, and markers of vascular damage. Int J Cardiol 2023;370:411. [PMID: 36336191 DOI: 10.1016/j.ijcard.2022.11.001] [Reference Citation Analysis]
|
| 4 |
Misra DP, Tomelleri A, Rathore U, Benanti G, Singh K, Behera MR, Jain N, Ora M, Bhadauria DS, Gambhir S, Kumar S, Baldissera E, Agarwal V, Campochiaro C, Dagna L. Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India. Diagnostics (Basel) 2022;12. [PMID: 36553110 DOI: 10.3390/diagnostics12123102] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Misra DP, Rathore U, Mishra P, Singh K, Thakare DR, Behera MR, Jain N, Ora M, Bhadauria DS, Gambhir S, Kumar S, Agarwal V. Comparison of Presentation and Prognosis of Takayasu Arteritis with or without Stroke or Transient Ischemic Attack-A Retrospective Cohort Study. Life (Basel) 2022;12. [PMID: 36431038 DOI: 10.3390/life12111904] [Reference Citation Analysis]
|
| 6 |
Misra DP, Jain N, Ora M, Singh K, Agarwal V, Sharma A. Outcome Measures and Biomarkers for Disease Assessment in Takayasu Arteritis. Diagnostics (Basel) 2022;12:2565. [PMID: 36292253 DOI: 10.3390/diagnostics12102565] [Reference Citation Analysis]
|
| 7 |
Misra DP, Rathore U, Kopp CR, Patro P, Agarwal V, Sharma A. Presentation and clinical course of pediatric-onset versus adult-onset Takayasu arteritis-a systematic review and meta-analysis. Clin Rheumatol 2022. [PMID: 35927524 DOI: 10.1007/s10067-022-06318-5] [Reference Citation Analysis]
|
| 8 |
Benallegue N, Kebir H, Alvarez JI. Neuroinflammation: Extinguishing a blaze of T cells. Immunol Rev 2022. [PMID: 35909230 DOI: 10.1111/imr.13122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Misra DP, Agarwal V. Management of refractory lupus nephritis: rationale to consider tacrolimus. Kidney Int 2022;101:1293. [PMID: 35597593 DOI: 10.1016/j.kint.2022.03.004] [Reference Citation Analysis]
|
| 10 |
Misra DP, Agarwal V. Th17.1 lymphocytes: emerging players in the orchestra of immune-mediated inflammatory diseases. Clin Rheumatol 2022. [PMID: 35546376 DOI: 10.1007/s10067-022-06202-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Robert M, Miossec P, Hot A. The Th17 Pathway in Vascular Inflammation: Culprit or Consort? Front Immunol 2022;13:888763. [DOI: 10.3389/fimmu.2022.888763] [Reference Citation Analysis]
|
